1. Home
  2. WKEY vs ADAG Comparison

WKEY vs ADAG Comparison

Compare WKEY & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$7.38

Market Cap

93.3M

Sector

Technology

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$2.97

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
ADAG
Founded
1999
2011
Country
Switzerland
China
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.3M
90.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WKEY
ADAG
Price
$7.38
$2.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$10.50
$8.00
AVG Volume (30 Days)
178.4K
211.8K
Earning Date
09-23-2025
08-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,994,000.00
$103,204.00
Revenue This Year
$32.29
$4,446.34
Revenue Next Year
$89.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$1.30
52 Week High
$19.80
$3.16

Technical Indicators

Market Signals
Indicator
WKEY
ADAG
Relative Strength Index (RSI) 39.49 72.46
Support Level $7.31 $1.69
Resistance Level $8.68 $2.94
Average True Range (ATR) 0.68 0.37
MACD -0.13 0.11
Stochastic Oscillator 2.47 83.54

Price Performance

Historical Comparison
WKEY
ADAG

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: